Diabetic dyslipidemia: Extending the target beyond LDL cholesterol

Stephen J. Nicholls, Pia Lundman, Jean Claude Tardif

Research output: Contribution to journalReview ArticleOtherpeer-review

9 Citations (Scopus)


Lowering low-density lipoprotein cholesterol plays an important role in therapeutic strategies designed to reduce cardiovascular risk. However, the residual clinical risk in statin trials suggests that additional therapies will be required to achieve more effective prevention of cardiovascular disease. The high prevalence of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol in diabetes presents further targets for the development of new cardioprotective therapies.

Original languageEnglish
Number of pages5
JournalEuropean Journal of Preventive Cardiology
Issue numberSUPPL. 1
Publication statusPublished - 1 Jan 2010
Externally publishedYes


  • Atherosclerosis
  • Diabetes
  • Risk factors

Cite this